Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -183,524 | -176,145 | -132,617 | -76,925 | -89,876 |
| Depreciation Amortization | 4,067 | 1,392 | 564 | 213 | 133 |
| Accounts receivable | -8,224 | -13,651 | -6,951 | 168 | -3,976 |
| Accounts payable and accrued liabilities | 1,887 | -3,563 | 18,646 | -3,261 | 4,232 |
| Other Working Capital | 3,864 | -14,032 | 16,364 | -6,337 | 665 |
| Other Operating Activity | 22,459 | 40,281 | -2,817 | 9,987 | 19,680 |
| Operating Cash Flow | $-159,471 | $-165,718 | $-106,812 | $-76,156 | $-69,142 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -207 | -2,450 | -217 | -62 | -396 |
| Purchase Sale Intangibles | -1,391 | -21,442 | -21,105 | -765 | -845 |
| Other Investing Activity | -1,391 | -21,442 | -21,281 | -765 | -859 |
| Investing Cash Flow | $-1,598 | $-23,892 | $-21,498 | $-827 | $-1,256 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 50,000 | 200,000 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 75,000 | N/A | N/A |
| Common Stock Issued | 31,975 | 77,140 | 91,574 | 72,584 | 137,226 |
| Other Financing Activity | -1,250 | -88,313 | -3,787 | 0 | 0 |
| Financing Cash Flow | $80,725 | $188,827 | $162,787 | $72,584 | $137,226 |
| Beginning Cash Position | 160,830 | 161,613 | 127,136 | 131,534 | 64,706 |
| End Cash Position | 80,486 | 160,830 | 161,613 | 127,136 | 131,534 |
| Net Cash Flow | $-80,344 | $-783 | $34,478 | $-4,399 | $66,828 |
| Free Cash Flow | |||||
| Operating Cash Flow | -159,471 | -165,718 | -106,812 | -76,156 | -69,142 |
| Capital Expenditure | -207 | -2,450 | -217 | -62 | -396 |
| Free Cash Flow | -159,678 | -168,168 | -107,029 | -76,217 | -69,539 |